Lin Y, Berdeja J, Raje N, et al. First-in-human multicenter study of BB2121 anti-BCMA CAR T cell therapy for relapsed/refractory multiple myeloma: updated results. EHA 2017, abstract 142.
RUNX1-remmers verhinderen groei primaire T-ALL-cellen
okt 2017 | Leukemie